title: Effects of olmesartan and imidapril on the plasma adiponectin, P-selectin, and MDA-LDL levels of diabetic nephropathy patients.
authors: Kouichi
authors: K
authors: Utsumi
authors: Fumihiko
authors: F
authors: Yasuda
authors: Yoko
authors: Y
authors: Watanabe
authors: Seiichiro
authors: S
authors: Higo
authors: Akio
authors: A
authors: Hirama
authors: Emiko
authors: E
authors: Fujita
authors: Kae
authors: K
authors: Ueda
authors: Akiko
authors: A
authors: Mii
authors: Tomohiro
authors: T
authors: Kaneko
authors: Masahiro
authors: M
authors: Mishina
authors: Yasuhiko
authors: Y
authors: Iino
authors: Yasuo
authors: Y
authors: Katayama
mesh_terms: D052242:Adiponectin / Q000097:blood*; D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D048289:Imidazolidines / Q000627:therapeutic use*; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism*; D008875:Middle Aged; D019007:P-Selectin / Q000097:blood*; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D052242:Adiponectin; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D007093:Imidazoles; D048289:Imidazolidines; D008077:Lipoproteins, LDL; D019007:P-Selectin; D013777:Tetrazoles; D008315:Malondialdehyde; C437965:olmesartan; C065166:imidapril